FRX Forest Road Acquisition Corp

Shareholder Class Action Filed Against Forest Laboratories, Inc. by the Law Firm of Schiffrin & Barroway, LLP RADNOR, Pa., March 16 /PRNewswire/ -- The following statement was issued today by the law firm of Schiffrin & Barroway, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of all securities purchasers of Forest Laboratories, Inc. (NYSE:FRX) ("Forest" or the "Company") between August 15, 2002 and August 31, 2004 inclusive (the "Class Period"). If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Schiffrin & Barroway, LLP (Marc A. Topaz, Esq. or Darren J. Check, Esq.) toll free at 1-888-299-7706 or 1-610-667-7706, or via e-mail at . The complaint charges Forest, Howard Solomon, and Kenneth Goodman with violations of the Securities Exchange Act of 1934. More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that the defendants failed to publish data showing that its SSRI's, Celexa and Lexapro, had mores side effects and raised the risk of suicide in children; (2) that the Company, despite the unpublished data, aggressively marketed the SSRIs; and (3) that the Company's Alzheimer's treatment was ineffective. On August 31, 2004, Forest announced that in a preliminary analysis, data from the first Phase III study of the investigational Alzheimer's disease treatment, neramexane, failed to achieve statistical significance. News of this shocked the marked. Shares of Forest fell $3.87 per share, or $8.44 percent, on September 1, 2004, to close at $41.98 per share. Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of Schiffrin & Barroway, which prosecutes class actions in both state and federal courts throughout the country. Schiffrin & Barroway is a driving force behind corporate governance reform, and has recovered in excess of a billion dollars on behalf of institutional and high net worth individual investors. For more information about Schiffrin & Barroway, or to sign up to participate in this action online, please visit http://www.sbclasslaw.com/ If you are a member of the class described above, you may, not later than May 10, 2005 move the Court to serve as lead plaintiff of the class, if you so choose. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Schiffrin & Barroway, or other counsel of your choice, to serve as your counsel in this action. CONTACT: Schiffrin & Barroway, LLP Marc A. Topaz, Esq. Darren J. Check, Esq. 280 King of Prussia Road Radnor, PA 19087 1-888-299-7706 (toll free) or 1-610-667-7706 Or by e-mail at DATASOURCE: Schiffrin & Barroway, LLP CONTACT: Marc A. Topaz, Esq. or Darren J. Check, Esq., both of Schiffrin & Barroway, LLP, +1-888-299-7706 or +1-610-667-7706, Web site: http://www.sbclasslaw.com/

Copyright